Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Language
Year range
1.
Braz. j. infect. dis ; 6(2): 63-73, Apr. 2002.
Article in English | LILACS | ID: lil-332308

ABSTRACT

INTRODUCTION: In developing countries, there is little information about the risk factors that predict noncompliance with tuberculosis (TB) treatment in hospitals. OBJECTIVE: This study analyzes possible factors associated with noncompliance with TB treatment among patients treated at HAA. DESIGN: A retrospective cohort study was made including all patients who initiated TB treatment at HAA, from January to December 1998. A standard form was used to review medical records and to collect data on each patient. This data was evaluated in comparison with data from the state TB control program. RESULTS: Of the 341 patients included in the study, 186 (61.2) were considered cured and 67 (22) were non-compliant. The factors associated with noncompliance were: previous anti-TB treatment (RR = 1.95, 95 CI 1.29 to 2.93), prescription of drugs other than the standard first-line regimen proposed by the Brazilian Health Ministry (Rifampin + Isoniazide + Pyrazinamide) (RR = 0.54, 95 CI 0.35 to 0.83), the need for hospitalization (RR = 2.19, 95 CI 1.46 to 3.29) and non-inclusion in the hospital s TB Control Program for treatment follow up (RR = 0.54, 95 CI 0.35 to 0.82). SETTING: Anuar Auad Hospital (HAA) GoiÔnia, Goißs, Brazil. CONCLUSION: Our results indicate the importance of establishing Tuberculosis Control Programs in hospitals, while paying special attention to patients with risk factors for noncompliance with TB treatment.


Subject(s)
Humans , Male , Female , Infant, Newborn , Infant , Child, Preschool , Child , Adolescent , Adult , Middle Aged , Acquired Immunodeficiency Syndrome , Hospitals , Patients , Treatment Refusal , Tuberculosis , Antitubercular Agents , Brazil , Isoniazid , Medical Records , Patients , Pyrazinamide , Rifampin , Risk Factors , Acquired Immunodeficiency Syndrome/complications , Tuberculosis
SELECTION OF CITATIONS
SEARCH DETAIL